ACDM News Item

Have your say – MHRA’s public consultation on proposals for legislative changes for clinical trials

Date: January 26, 2022

Dear Colleague,

We have just launched our 8-week public consultation on proposals for legislative changes for clinical trials.

We want to streamline clinical trial approvals, enable innovation, enhance clinical trials transparency, enable greater risk proportionality, and promote patient and public involvement in clinical trials.

We would like to hear from clinical trial participants, researchers, developers, manufacturers, sponsors, investigators, healthcare professionals and the wider public to help shape improvements to the legislation for clinical trials.

You can read more about our proposals in our Press release and consultation document.

Please do share this email and the social media links below with your networks and contacts so that we can get the broadest possible response.

The consultation will close at 11pm on Monday, 14 March 2022.

Thank you for your support.

The Medicines and Healthcare products Regulatory Agency

https://www.gov.uk/government/consultations/consultation-on-proposals-for-legislative-changes-for-clinical-trials

Explore More News

Regulatory Considerations DMEG to Review Health Canada’s Draft Guidance

Thank you to the Regulatory Considerations DMEG for sharing this update. Health Canada . . .

Recent update from the regulatory landscape in clinical data management

Thank you to the Regulatory Considerations DMEG for sharing this update. On July 15 the . . .

Regulatory Considerations DMEG Update – June 2026

Please read the following update from the Regulatory Considerations DMEG: Regulators have . . .

FDA Announces New Initiative for Real-Time Clinical Trials

The U.S. Food and Drug Administration (FDA) has announced a new initiative to support the . . .

Get to know ACDM Board Member Jennifer Duff

We caught up with one of ACDM’s new Board Members, Jennifer Duff, to learn more about her. . . .

Recent News in Regulatory Landscape

The ACDM Regulatory Considerations DMEG have kindly put together a short news piece . . .

Real-Time Clinical Data Flow: Why the FDA’s New Pilot Validates the Data Flow Modernization Agenda

Tamer Chowdhury, on behalf of ACDM Technology DMEG. On April 28, FDA Commissioner Dr. . . .

Bridging the Behaviour Gap: The Human Skills Redefining Clinical Data Management (ACDM26 Workshop Recap)

This article has been written by Gail Kniveton, who delivered the workshop “Bridging the . . .

Regulatory Considerations DMEG reviews recent MHRA regulatory updates

The ACDM Regulatory considerations DMEG Regulatory considerations reviewed several recent . . .

ACDM26 Berlin: Shaping the Future of Clinical Data Management

The ACDM Annual Conference returned to Berlin in March 2026, welcoming the global clinical . . .

Member News Update from Lab Data Solutions LLC

This news piece has been submitted by Lab Data Solutions LLC We’re Attending US Summit . . .

Welcome Veramed as a corporate member

The Association for Clinical Data Management (ACDM) is delighted to welcome Veramed as a . . .